The Psychedelics & Mental Health survey performed by Verywell Mind examines what Americans know and feel about psychedelics as mental health treatments.
The poll, adding to other similar studies, surveyed over 1,800 Americans over 18 across various ages, races and demographics. The context included past years’ research pointing at ketamine and psilocybin’s promising treatment results for addiction, depression and PTSD, while a growing influx of ketamine-assisted therapy is making new treatment options even more available.
